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Change in physical activity level and
clinical outcomes in older adults with knee
pain: a secondary analysis from a
randomised controlled trial
Jonathan G. Quicke*, Nadine E. Foster, Peter R. Croft, Reuben O. Ogollah and Melanie A. Holden
Abstract
Background: Exercise interventions improve clinical outcomes of pain and function in adults with knee pain due to
osteoarthritis and higher levels of physical activity are associated with lower severity of pain and higher levels of
physical functioning in older adults with knee osteoarthritis in cross-sectional studies. However, to date no studies
have investigated if change in physical activity level during exercise interventions can explain clinical outcomes of
pain and function. This study aimed to investigate if change in physical activity during exercise interventions is
associated with future pain and physical function in older adults with knee pain.
Methods: Secondary longitudinal data analyses of a three armed exercise intervention randomised controlled trial.
Participants were adults with knee pain attributed to osteoarthritis, over the age of 45 years old (n = 514) from
Primary Care Services in the Midlands and Northwest regions of England.
Crude and adjusted associations between absolute change in physical activity from baseline to 3 months
(measured by the self-report Physical Activity Scale for the Elderly (PASE)) and i) pain ii) physical function (Western
Ontario and McMaster Universities Osteoarthritis Index) and iii) treatment response (OMERACT-OARSI responder
criteria) at 3 and 6 months follow-up were investigated using linear and logistic regression.
Results: Change in physical activity level was not associated with future pain, function or treatment response
outcomes in crude or adjusted models at 3 or 6 months (P > 0.05). A 10 point increase in PASE was not associated
with pain β = − 0.01 (− 0.05, 0.02), physical function β = − 0.09 (− 0.19, 0.02) or likelihood (odds ratio) of treatment
response 1.02 (0.99, 1.04) at 3 months adjusting for sociodemographics, clinical covariates and the trial intervention
arm. Findings were similar for 6 month outcome models.
Conclusions: Change in physical activity did not explain future clinical outcomes of pain and function in this study.
Other factors may be responsible for clinical improvements following exercise interventions. However, the PASE
may not be sufficiently responsive to measure change in physical activity level. We also recommend further
investigation into the responsiveness of commonly used physical activity measures.
Trial registration: (ISRCTN93634563). Registered 29th September 2011.
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Background
Knee pain attributable to osteoarthritis (OA) is both
common and disabling in older adults [1]. Exercise and
physical activity (PA), including lower limb muscle
strengthening and aerobic exercise (for example walking,
cycling and swimming) are core recommended treat-
ments in OA clinical guidelines [1–3]. Such interven-
tions are associated with, on average, small to medium
effect sizes in terms of reduction in pain and improve-
ments in physical function compared to non-exercise
control groups [4–6], although improvements may not
be maintained over the longer-term. In order to optimise
the effectiveness of exercise interventions, it is important
to understand the active components that contribute to
improved clinical outcomes [7].
Higher levels of physical activity have been shown to be
associated with lower severity of pain and higher physical
function in older adults with knee pain in cross-sectional
studies [8]. It is plausible that changes in participants’
physical activity level as a result of exercise interventions
may explain changes in pain and physical functioning ei-
ther directly or indirectly. For example, increase in levels
of moderate and vigorous cardiovascular intensity physical
activity are associated with weight loss in longitudinal co-
horts with or at risk of knee OA [9] which is associated
with reduced pain and improved function in those who
are overweight [10]. However, to date, no studies have in-
vestigated the association between change in physical ac-
tivity level and clinical outcomes of pain and function.
The aim of this study, therefore, was to investigate if
change in physical activity level is associated with future
pain, physical function and overall response to treatment
[11] in older adults with knee pain.
Methods
Design
This study involved secondary analyses of data from a
multi-centre, pragmatic, three-parallel group, rando-
mised controlled trial (RCT) of three physical therapist-
led exercise interventions (The Benefits of Effective Ex-
ercise for knee Pain-BEEP trial ISRCTN 93634563) [12].
Longitudinal data from all three groups at baseline, three
months (following treatment in two of three groups) and
six months (following treatment in all groups) were
combined, with a priori adjustment for intervention
group allocation. Ethical approval was provided by the
North West 1 Research Ethics Committee, Cheshire, UK
(REC reference 10/H1017/45). Full detail of the RCT is
available elsewhere [12] but a concise summary is pro-
vided below for context.
Participants
Participants were adults with knee pain attributable to
OA from the BEEP trial (n = 514). Inclusion criteria
were a clinical diagnosis of knee OA made by either a
general practitioner or a primary care research nurse
based on age (being 45 years old or older), the presence
of pain and/or stiffness in one or both knees [1] and the
exclusion of knee pain due to other sources, such as
those who had pain due to trauma or recent injury, po-
tentially serious pathology other than OA (such as ma-
lignancy or rheumatoid arthritis) and those who had
undergone previous total knee replacements. Those with
exercise contraindications (such as those with unstable
cardiovascular disorders, severe hypertension or congest-
ive heart failure) and those unable to travel to physical
therapy treatment centres were also excluded [12].
Participants were recruited from 65 general practices
in the midlands and northwest regions of England from:
i) records of general practitioner consulters with knee
pain in the last year, ii) those referred to physical therapy
with knee pain and, iii) adults registered at participating
general practices who responded to a questionnaire and
reported knee pain [12].
Trial intervention arms
The three physical therapist-delivered exercise interven-
tion arms were: usual care (UC), individually tailored ex-
ercise (ITE) and targeted exercise adherence (TEA). All
participants received an advice and information booklet
in addition to an exercise programme delivered one-to-
one for up to three (UC and ITE) and six months
(TEA). Additional intervention detail is provided in
Additional file 1: Table S1.
Outcomes
Pain and physical function
Knee pain severity and physical function were assessed
using the Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) pain and function sub-
scales [13]. The pain subscale comprises five items
measuring self-reported pain during various activities
and gives a total score ranging from 0 (no pain) to 20
(maximum pain). The physical function subscale com-
prises 17 items and measures the self-reported difficulty
an individual has with a broad range of physical functions
giving a total score ranging from 0 (no disability) to 68
(maximum disability). Both subscales have been widely
used in knee OA studies and their clinimetric properties
have been widely investigated elsewhere [13–15].
Treatment response
Clinically important response to treatment was assessed
using the Outcome Measures in Rheumatology Clinical
Trials clinical responder criteria (OMERACT-OARSI re-
sponder criteria) [11, 16]. This internationally agreed
measure combines outcome data on pain and physical
function from the WOMAC scales with patient’s global
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assessment of change (recorded using a 6 point Likert
Scale) [11, 16]. Treatment responders are classified as
those who either make a large improvement in pain or
function (≥50% improvement and absolute change ≥20
in a 0–100 scale) or a small improvement (≥20% im-
provement and absolute change≥10 in a 0–100 scale) in
two out of three of pain, physical function or global as-
sessment of change (at follow-up compared to baseline).
Determinants
Change in physical activity
Absolute change in physical activity from baseline to
three month follow-up (referred to henceforth as
“change in physical activity”) was calculated by subtract-
ing baseline physical activity score from follow-up phys-
ical activity score at three months using the self-report
Physical Activity Scale for the Elderly (PASE) [17]. The
PASE scale (scored from 0 to over 400 with higher
scores indicating higher levels of physical activity) mea-
sures physical activity in the previous week summed
from questions regarding the frequency and duration of
household, leisure time and work physical activity. It has
demonstrated construct validity in terms of correlation
with 6 min walk test (r = 0.35) and knee strength (0.41)
in older adults with knee pain [18] and test-retest reli-
ability in older adults (intra-class correlation 0.75) [17].
The PASE scale has been used in previous longitudinal
studies of knee pain and OA [19–21].
Potential confounders
A range of sociodemographic and clinical covariates
measured within the BEEP dataset may be potential con-
founders of the relationship between change in physical
activity and clinical outcomes due to their association
with both physical activity [8] and clinical outcome [22,
23]. These included age, gender, Body Mass Index
(BMI), individual socioeconomic status [24], employ-
ment status, comorbidities (categorised into none, one
and two or more), depression measured by the Personal
Health Questionnaire (PHQ 8) [25], anxiety measured
by the generalized Anxiety Disorder Questionnaire
(GAD-7) [26], and widespread pain measured by the
Manchester Widespread Pain criteria [27].
Analyses
All analyses were carried out using STATA version 13.1
[28] and all primary longitudinal analyses utilised a
multiply imputed dataset. Multiple imputation (25 impu-
tations) using chained equations was used to adjust for
the effect of missing data by maximising sample size and
reducing the possible bias associated with loss to follow-
up and missing data [29] since there was between 12
and 22% missing clinical outcome data at 3 and
6 months. A wide range of sociodemographic and
clinical variables available within the BEEP dataset, in-
cluding the outcome variables, were used in the imput-
ation model [30].
Descriptive statistics
Baseline characteristics (complete case) together with
longitudinal descriptive statistics (at baseline, three and
six months) of physical activity, change in physical activ-
ity (measured by the PASE) and clinical outcomes of
pain, physical function (WOMAC) and treatment re-
sponse (OMERACT-OARSI responder criteria) were
summarised using means and standard deviations (SD)
or frequency and percentage as appropriate.
Analyses to investigate the association between change
in physical activity and clinical outcome
Associations between change in physical activity and
clinical outcomes of pain, physical function and treat-
ment response at three and six months were determined
using linear and logistic regression. Both univariable and
multivariable models were fitted. ANCOVA type multi-
variable models were used where the clinical outcome
variable of interest (pain or function) at 6 months (and
subsequently 12 months) were adjusted for baseline clin-
ical severity (pain in the pain and treatment response
models, and function in the function model), potential
confounders and the trial intervention arm. The a priori
decision to hold the intervention arm within multivari-
able models was made to account for any between trial
arm treatment effects (although similar clinical improve-
ments were found in all groups). Additional methodo-
logical detail regarding adjusted model building is
provided in the Additional file 2.
Sensitivity analyses
Sensitivity analyses on missing data was performed by
use of complete case analysis (CCA), which restricts the
analysis to subjects with complete data on the variables
involved in the analysis. CCA assumes that missing cases
are missing completely at random and makes the as-
sumption that results would be similar to intended sam-
ple results [31].
Results
Descriptive statistics
Table 1 describes the baseline characteristics of the 514
BEEP trial participants. The sample was 51% female with
a participant mean (SD) age of 62.8 (9.7) years. Mean
WOMAC pain score (SD) was 8.4 (3.5) and physical
function score was 28.1 (12.2) suggesting that on average
participants had moderate levels of clinical severity.
Mean physical activity score, measured by the PASE,
was 177 (83.3) (see Table 2).
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The proportion of the baseline sample lost to follow up
was 17% at three months and 11% at six months. For in-
formation, participants lost to follow-up had slightly worse
pain and function at baseline, higher levels of depression
and anxiety at baseline and were less likely to have used
facilities for physical activity in the last 7 days [30]. Mean
PASE increased to 192.1 (87.9) at three month
follow-up and then remained relatively stable at six
month follow-up 190.5 (89.3). Clinical outcome scores
of pain and function improved over time with 45%
classified as treatment responders at three months
and 52% at six months follow-up. At three months,
mean WOMAC pain and function were 6.7 (3.6) and
23.6 (12.5) respectively, changing to 6.3 (3.9) and 21.7
(13.7) at six month follow-up (see Table 2).
The mean PASE change score between baseline and
three months was an increase of 15.1 with substantial in-
dividual variation as indicated by a standard deviation of
87.4. Change scores for physical activity and clinical out-
comes are reported in Table 3.
Associations between change in physical activity and
clinical outcome
Univariable models showed change in physical activity
was not significantly associated with any of the three
clinical outcomes of pain, physical function (Tables 4
and 5) or treatment response at both three and six
months (p > 0.05) (Table 6).
Change in physical activity remained non-significantly
associated with clinical outcomes in all multivariable
clinical outcome models adjusting for age, continuous
BMI, pain duration, depression, the trial intervention
Table 1 Baseline characteristics
Characteristic Total (n = 514)
Age, n (%), years
45–49 52 (10)
50–59 153 (30)
60–69 183 (36)
70–79 99 (19)
≥80 27 (5)
Female, n (%) 262 (51)
BMI, n (%), *
Underweight/ normal 97 (20)
Overweight 208 (42)
Obese 192 (39)
Currently employed n (%) * 214 (42)
Socioeconomic category, n (%) *
Professional 166 (43)
Intermediate 94 (25)
Routine and manual work 124 (32)
Comorbidities, n (%)
None 164 (32)
1 comorbidity 180 (35)
2 or more comorbidities 170 (33)
PHQ 8, 0–24, mean (SD) * 4.0 (+/− 4.7)
WOMAC, mean (SD)
Pain, 0–20, * 8.4 (+/− 3.5)
Function, 0–68, * 28.1 (+/− 12.3)
Stiffness, 0–8, * 3.7 (+/− 1.7)
Knee pain duration, n (%), years *
≤ 1 125 (25)
More than1 but < 5 198 (39)
More than 5 but < 10 94 (19)
10+ 91 (18)
Widespread pain n (%) * 79 (15)
Footnote: Baseline descriptive statistics based on complete cases; * = subject to
missing data (hence individual item frequencies may not add to total sample).
Missing data was 2% in primary clinical variables, less than 10% in all
remaining variables except socioeconomic category which was 25% missing.
Body Mass Index: less than 25 = underweight/ normal, 25 or more but less
than 30 = overweight, 30 or more = obese. Comorbidities included (in
descending order of frequency) Hypertension, Asthma, Diabetes, Angina, Heart
attack and Heart failure
Abbreviations: BMI Body Mass Index, PHQ 8 Personal Health Depression
Questionnaire (higher scores indicate lower mood), SD Standard deviation;
Widespread pain = Manchester Widespread Pain [27]; WOMAC Western Ontario
and McMaster Universities Osteoarthritis Index
Table 2 Physical activity and clinical outcome longitudinal
summary statistics
Variables (range) Baseline 3 months 6 months
PASE (0–400+) 177.0 (83.3) 192.1 (87.9) 190.5 (89.3)
WOMAC pain (0–20) 8.4 (3.5) 6.7 (3.6) 6.3 (3.9)
WOMAC function (0–68) 28.1 (12.2) 23.6 (12.5) 21.7 (13.7)
OMERACT-OARSI response (%) NA 45 52
Footnote: Multiple imputed data (combined results from 25 imputed datasets). All
values are mean scores (standard deviation) except OMERACT-OARSI response
which are given in percentages. All scores indicate higher levels of the variable
except WOMAC function with higher scores indicating lower functioning
Abbreviations: OMERACT-OARSI Outcome Measures in Rheumatology Clinical
Trials-Osteoarthritis Research Society International, PASE Physical Activity Scale
for the Elderly, WOMAC Western Ontario and McMaster Universities
Osteoarthritis Index
Table 3 Physical activity, pain and function change scores
Change variable Mean score baseline
to 3 months(SD)
Mean score baseline
to 6 months(SD)
Change in PASE 15.1 (87.4) 13.5 (86.9)
Change in WOMAC pain −1.6 (3.2) −2.1 (3.5)
Change in WOMAC function −4.5 (10.1) −6.4 (11.8)
Footnote: Multiple imputed data (combined results from 25 imputed datasets);
all change scores calculated by subtracting the score at baseline from the
score at three or six month follow up; Higher change in PASE scores indicate
higher physical activity at follow up compared to baseline; Negative change in
WOMAC pain and function scores indicate reduced pain and higher function
at follow-up compared to baseline
Abbreviations: PASE Physical Activity Scale for the Elderly, WOMAC Western
Ontario and McMaster Universities Osteoarthritis Index
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arm and baseline pain/function (P > 0.05) (see Tables 4,
5 and 6). An increase of 10 PASE points between base-
line and three months had a non-statistically significant,
adjusted association with WOMAC pain at three (β = −
0.01 (95% Confidence Interval − 0.05, 0.02)) and six (β =
− 0.02 (− 0.06, 0.02)) months. Interpreting these best
estimate β coefficients, for every increase in physical ac-
tivity of ten points on the PASE, WOMAC pain score
decreased by 0.01 at three months and 0.02 at six
months. These results are not statistically significant
since the 95% confidence intervals cross zero. Simi-
larly, an increase of 10 points on the PASE scale
Table 4 The association between change in physical activity level and pain and function at three months follow-up
Key: White = Unadjusted Models; Blue = Adjusted pain at 3 months model; Gold = Adjusted physical function at 3 months model
Footnotes: Multiple imputed data; multiple linear regression adjusted models selected via backwards elimination holding treatment arm and change in physical
activity in the model. * = statistically significant β coefficient P < 0.05; ** = statistically significant β coefficient P < 0.01. Higher WOMAC scores indicate higher pain
and worse function. Higher PASE score indicates higher level of physical activity, #absolute change in PASE calculated by subtracting the baseline score from the
score at three months. Higher PHQ8 depression scores indicate worse depression
Abbreviations: β Unstandardized coefficients, BMI Body Mass Index; CI=Confidence Interval, PASE Physical Activity Scale for the Elderly, PHQ8 Personal Health
Questionnaire, WOMAC Western Ontario and McMaster Osteoarthritis Index
Table 5 The association between change in physical activity level and pain and function at six months follow-up
Key: White = Unadjusted Models; Blue = Adjusted pain at 6 months model; Gold = Adjusted physical function at 6 months model
Footnotes: Multiple imputed data, multiple linear regression adjusted models selected via backwards elimination holding treatment arm and change in physical
activity in the model. Regression coefficients shown are rounded to two decimal places and a score of − 0.00 is used to indicate a very small yet negative
confidence interval coefficient. * = statistically significant β coefficient P < 0.05; ** = statistically significant β coefficient P < 0.01. Higher WOMAC scores indicate
higher pain and worse function. Higher PASE score indicates higher level of physical activity, #absolute change in PASE calculated by subtracting the baseline
score from the score at three months. Higher PHQ8 depression scores indicate worse depression
Abbreviations: β Unstandardized coefficients, BMI Body Mass Index, CI Confidence Interval, PASE Physical Activity Scale for the Elderly, PHQ8 = Personal Health
Questionnaire, WOMAC Western Ontario and McMaster Osteoarthritis Index
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had a non-statistically significant adjusted associ-
ation with function at three β = − 0.09 (− 0.19, 0.02) and
six months β = − 0.09 (− 0.22, 0.04) and, treatment re-
sponse at three months OR = 1.02 (0.99, 1.04) and six
months OR = 1.01 (0.98, 1.04). Interpreting the treatment
response best estimate odds ratios, for every increase in
physical activity of ten points on the PASE, participants
had a 2% increase in the odds of being able to be classified
as a treatment responder using the OMERACT-OARSI
criteria at three month follow-up and 1% increase in odds
at six month follow-up but these findings were not statisti-
cally significant since the 95% confidence interval odds ra-
tios cross one.
Complete case sensitivity analyses, investigating the ad-
justed association between a 10 point increase in PASE
and clinical outcomes of WOMAC pain and function at 3
and 6 months produced similar non-statistically signifi-
cant associations (results not shown).
Discussion
Main findings
This study investigated whether change in physical activ-
ity was associated with future clinical outcomes of pain
and physical function in older adults with knee pain at-
tributable to OA. This question is novel and important
since change in physical activity may explain clinical im-
provements following exercise interventions and inform
future interventions. The main finding from this RCT
was that change in physical activity level was not associ-
ated with future pain, physical functioning or treatment
response at either three or six month follow-up. Small β
coefficients were expected given the difference in scale
between the PASE (0–400+) and WOMAC pain and
function scores (0–20 and 0–68 respectively) (since the
PASE scale is larger by approximately a factor of 20 than
the WOMAC pain scale). However, even taking this in
to account and allowing for a 10 point change in PASE,
the magnitude of associations were very small, non-
statistically significant and do not appear to be of clinical
importance (Tables 4, 5 and 6). For example, extrapolat-
ing from the β coefficients, changing physical activity by
a full standard deviation (83 points on the PASE) would
be associated with less than a 1 point change in
WOMAC pain or function at either three or six months.
Similarly, large changes in physical activity would only
have a very small effect on the odds of being an
OMERACT-OARSI responder.
The null association findings (Tables 4, 5 and 6) sug-
gest that change in overall general physical activity level,
as measured by the PASE, does not explain clinical out-
come following exercise intervention within the BEEP
trial and that other variables may be responsible for the
observed improvements in pain and function (see Table
2). For example, lower limb strengthening [32] or psy-
chosocial factors (such as outcome expectations, atten-
tion and monitoring, the interest and empathy expressed
by physiotherapists and the credibility of the interven-
tion) may contribute to improvements in pain and func-
tion [33, 34].
There is also a separate or further explanation for the
null findings. Measuring change in physical activity
using the self-report PASE involves a number of
Table 6 The association between change in physical activity level and treatment response at three and six months follow-up
Key: White = Unadjusted Models; Blue = Adjusted OMERACT-OARSI treatment response models
Footnotes: Multiple imputed data, multiple logistic regression adjusted models selected via backwards elimination holding treatment arm and change in physical
activity in the model. Higher WOMAC scores indicate higher pain. * = statistically significant OR P < 0.05; ** = statistically significant OR P < 0.01. Higher PASE score
indicates higher level of physical activity, #absolute change in PASE calculated by subtracting the baseline score from the score at three months. Higher PHQ8
depression scores indicate worse depression
Abbreviations: β Unstandardized coefficients, CI Confidence Interval, OMERACT OARSI Osteoarthritis Research Society International set of responder criteria for
osteoarthritis clinical trials, PASE Physical Activity Scale for the Elderly, PHQ8 Personal Health Questionnaire, WOMAC Western Ontario and McMaster Osteoarthritis
Index; yr. = year
Quicke et al. BMC Musculoskeletal Disorders  (2018) 19:59 Page 6 of 9
limitations that may increase the chance of a Type II
error (i.e. rejecting an association between change in
physical activity and clinical outcome if one exists). Al-
though the PASE has been highlighted as a promising
measure of physical activity in older adults with OA
[35], all self-report measures of physical activity can ei-
ther over- or under- estimate actual physical activity level
[36] since they are at risk of recall bias (through errors in
memory and activity recall), misclassification of physical
activity intensity and duration [15, 37], and social desirabil-
ity bias by participants [38]. Furthermore, modelling
change in physical activity is methodologically challenging
and using an absolute change score between two time-
points may compound measurement errors and reduce re-
gression coefficient precision, biasing our findings towards
the null [39].
The PASE minimal detectable change statistic (87),
which measures the threshold for a “real” change that
with 95% confidence is beyond measurement error [40],
is considerably larger than the mean change detected in
the BEEP dataset (15.1). This suggests that the mean
change in PASE scores detected during the exercise inter-
ventions was relatively small, potentially affected by meas-
urement error and perhaps insufficient to influence
clinical outcomes or alternatively that the PASE may have
inadequate responsiveness in older adults with joint pain.
To the authors’ knowledge, this is the first study to ex-
plicitly investigate the association between change in
physical activity level and clinical outcomes of pain and
function in older adults with knee pain attributable to
OA. However, similar studies have investigated the asso-
ciation between change in physical activity level and dis-
ability in those with low back pain [41] and pain severity
and physical function outcomes in those with fibromyal-
gia [42, 43]. Similar to our findings, no association was
found in the back pain study using either self-report or
accelerometer measured physical activity [41], however,
associations were found between change in physical activ-
ity and future clinical outcomes in the two fibromyalgia
studies [42, 43]. Whilst the aetiological differences be-
tween knee pain attributed to OA and fibromyalgia are
likely to be substantial and prevent direct comparison,
these findings do suggest it is possible to detect associa-
tions if they exist between self-report change in physical
activity and clinical outcomes despite the previously dis-
cussed challenges in measuring change in physical activity.
Strengths and limitations
The strengths of this study were the ability to investigate
both univariable and adjusted associations between
change in physical activity and future clinical outcomes at
two separate time-points. The use of multiple imputation
helped preserve sample size, reducing the risk of bias due
to loss to follow-up [29] whilst the sensitivity analysis
added strength to the primary findings by exploring the
dataset under different missing data assumptions.
The main study limitation, relating to the challenges
in measuring change in physical activity, has been dis-
cussed above. With our available data we were unable to
investigate levels of different types of physical activity,
for example, time spent in strengthening or different
cardiovascular intensities of exercise. Different types of
physical activity may have had different effects on out-
come. Another concern for our analysis is temporal bias.
Temporal bias occurs when the inference about proper
temporal sequence of cause and effect is erroneous [44].
Attempts were made to measure the exposure of inter-
est- change in physical activity level (baseline to three
months) prior to the clinical outcomes (at three and six
months). Nevertheless, change in pain or physical func-
tion may have occurred prior to any change in physical
activity, meaning we cannot be sure about the direction
of any potential cause and effect. In handling missing
data using multiple imputation for our analysis, we made
the assumption that our data was “missing at random”
(MAR) [29] since we deemed it likely that missing values
could be estimated from observed values. If any missing
data was “missing not at random” (MNAR) i.e. there are
systematic differences between missing and observed
values even after the observed data are taken into ac-
count then our multiple imputed analysis would be at
risk of bias [29].
Finally, before generalising our findings it is important
to remember this sample population were older adults
with knee pain attributed to clinically diagnosed OA
from a RCT of exercise interventions. Other populations
of older adults with knee pain, for example, those who
did not consent to exercise interventions may have dif-
ferent clinical outcomes with changing their physical ac-
tivity levels.
Implications
Although change in physical activity was not shown to
be associated with clinical outcomes of pain and physical
function, insufficiently active older adults with knee pain
can still be advised to increase their physical activity
levels as able, in order to achieve the associated general
health benefits [45–48] with the reassurance that modest
increases in physical activity are not associated with in-
creasing pain or deterioration in function at a group level.
In order to select the most appropriate physical activ-
ity measure for longitudinal studies measuring change in
physical activity in older adults with knee pain, future
research could investigate and compare the reliability
and responsiveness of the PASE alongside other recom-
mended measures of physical activity such as the Inter-
national Physical Activity Questionnaire (IPAQ) [37] and
direct measures such as pedometry and accelerometry.
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The inclusion criteria for this trial sample was based
on older adults with knee pain regardless of baseline
level of physical activity. Future studies could investigate
specific subgroups of older adults with knee pain, such
as those who are inactive, who may plausibly respond
differently to increases in physical activity than all adults
with knee pain or those currently meeting guideline rec-
ommended activity levels.
Conclusions
Change in physical activity level was not associated with
future pain, physical function or the proportion of par-
ticipants who could be classified as treatment responders
in this secondary analysis of a randomised trial dataset.
Hence other factors may be responsible for improve-
ments in these clinical outcomes following exercise in-
terventions. Accurately measuring change in physical
activity in older adults with knee pain remains a chal-
lenge and the PASE, although useful for capturing popu-
lation snap shots of physical activity level, may not be
sufficiently responsive to detect changes over time in
this clinical population. We recommend the further in-
vestigation of responsiveness in commonly utilised mea-
sures of physical activity for older adults with joint pain
including the PASE to aid future longitudinal studies
assessing change in physical activity.
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